Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Purpura, Thrombocytopenic, Idiopathic × romiplostim × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thrombocytopenia 2 Lymphoma, Non-Hodgkin 2 Purpura, Thrombocytopenic, Idiopathic 1 Purpura, Thrombocytopenic 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Hodgkin Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00515203 2014-07-25

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Amgen

Phase 1/2 Completed

22 enrolled 13 charts 1 FDA

Purpura, Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡